Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.15 | N/A |
| PEG Ratio (TTM) | -6.22 | N/A |
| P/S Ratio (TTM) | 1.47 | N/A |
| P/B Ratio (TTM) | 2.77 | N/A |
| P/FCF Ratio (TTM) | 10.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.48 | N/A |
| Price to 5YR AVG FCF Ratio | 19.99 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.75% | N/A |
| ROE (TTM) | 11.48% | N/A |
| Net Profit Margin (TTM) | 6.42% | N/A |
| ROIC 5YR AVG | 19.72% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 172.20% | 63.14% | 32.93% |
| Revenue | 4.41% | 5.26% | 5.45% |
| Net Income | 168.91% | 61.24% | 30.48% |
| Cash Flow | -1,051.07% | 7.89% | 507.49% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.22 | N/A |
| Quick Ratio (TTM) | 1.81 | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | 60.55 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 6.05 | N/A |
| LTL to 5YR AVG FCF | 1.37 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.52% | N/A |